ArticleCancers2024
Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.
Sainab Totonji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleCancers2024
Sainab Totonji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.